Abstract
Mesenchymal stem cells (MSCs) hold great promise for improving myocardial recovery after ischemia. The cardiothoracic surgeon is uniquely positioned to be at the forefront of any clinical application of this therapy. As such, a basic understanding of stem cells and the cytokines that affect stem cell function will be an essential component of the surgeon's ever-expanding knowledge base. This review provides: (1) a general overview of stem cells and MSCs in particular, (2) critically analyzes several cytokines known to alter MSC function, and (3) discusses methods to manipulate cytokine-activated MSCs to improve MSC function for potential clinical application.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Cytokines / blood*
-
Graft Enhancement, Immunologic / methods
-
HMGB Proteins / blood
-
Hepatocyte Growth Factor / blood
-
Humans
-
Inflammation Mediators / blood*
-
Insulin-Like Growth Factor I / metabolism
-
Mesenchymal Stem Cell Transplantation*
-
Myocardial Ischemia / immunology*
-
Myocardial Ischemia / surgery*
-
Paracrine Communication / immunology
-
Transforming Growth Factor beta1 / blood
-
Transplantation Immunology / immunology*
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Cytokines
-
HMGB Proteins
-
Inflammation Mediators
-
Transforming Growth Factor beta1
-
Tumor Necrosis Factor-alpha
-
Hepatocyte Growth Factor
-
Insulin-Like Growth Factor I